Jimini Health has announced $17 million in seed funding to advance its clinician-supervised AI platform designed for behavioral health providers. The round was led by M13, with participation from Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind, bringing the company’s total funding to more than $25 million.
The New York-based company is focused on addressing a growing challenge across behavioral health systems: the widespread, unsupervised use of general-purpose AI tools by patients seeking mental health support. As patient adoption accelerates, providers face increasing clinical, operational and regulatory pressure to integrate AI safely into care delivery.
More than 5.4 million U.S. adolescents and young adults are currently using AI chatbots for mental health advice, while over 1 million weekly conversations with ChatGPT reportedly include indicators of suicidal ideation. These trends have raised concerns about the absence of clinical oversight in patient-AI interactions.
"When 1 million people a week are discussing suicide with a product that was never designed to handle it, that's not an edge case, it's a systemic gap," said Morgan Blumberg, Partner at M13. "Jimini is building the clinical infrastructure this category has never had: real supervision, real clinicians, real oversight."
Jimini’s platform, Sage, is designed as a patient-facing AI system embedded within provider organizations rather than a standalone consumer tool. The platform enables clinicians to maintain visibility and control over all patient interactions, ensuring that care decisions remain with licensed professionals. The system follows clinician-defined care plans and does not operate autonomously.
The company has developed its infrastructure to align with emerging regulatory frameworks, including recent initiatives from the Centers for Medicare & Medicaid Services and the FDA aimed at supporting safe adoption of clinical AI. Jimini’s model is structured to support reimbursement pathways as these policies evolve.
"As CMS and other payers create new pathways for technology-enabled care, the stakes for getting AI right in behavioral health have never been higher," said former Acting Administrator of the Centers for Medicare and Medicaid Services under President Obama and Jimini investor Andy Slavitt. “Jimini is building what the industry needs.”
The company plans to expand Sage’s capabilities across additional care settings and partner with large behavioral health organizations nationwide, focusing on integration with existing clinical workflows, including EHR systems and hybrid care models.
"It is entirely clear to us, and our early adopter clinical partners, that patient-facing LLMs will soon be a core part of patient care in behavioral health," said CEO Luis Voloch. “We are looking for the forward-thinking health system partners who want to define what responsible AI looks like in this category – before it is defined for them.”
Click here for the original news story.